FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307805944> ?p ?o ?g. }

• W4307805944 endingPage "A282" @default.
• W4307805944 startingPage "A282" @default.
• W4307805944 abstract "Abstract The results from the SGLT-2 inhibitors cardiovascular outcome trials were generalized to all, despite that non-Hispanic Black (hereafter, Black) participants were underrepresented. Our goal was to evaluate, among patients with type 2 diabetes, the risk of heart failure hospitalizations among black vs non-Hispanic White (hereafter White) patients initially prescribed empagliflozin. | We performed a multicenter retrospective study using clinical data derived from Electronic Medical Records (EMR's) from adults with type 2 diabetes cared for at 4 healthcare systems (UNC Health, Duke Health, MUSC, and ECU Health) who were prescribed empagliflozin between August 2014 and December 2019. Our primary outcome was time to first heart failure hospitalization. We wanted to understand if the outcomes were different in Black vs White patients with previous hospitalizations for heart failure that occurred prior to an empagliflozin prescription. Cumulative probability of heart failure hospitalization by race was estimated using the cumulative incidence function. The association of race with risk of heart failure hospitalization was evaluated using multivariable Cox hazards models. Hazard ratio (HR) and 95% confidence interval (CI) are provided as measures of strength of association and precision, respectively. | A total of 704 patients with previous heart failure hospitalizations were eligible. Mean age by race category (Black/White) was 60.2 vs 64.3 years (p &lt; 0. 0001); 42.8% vs 61. 0% were males (p &lt; 0. 0001) and 81.2% vs 73.2% had a history of hypertension respectively. Black patients were significantly younger and predominantly female. Cumulative probability of heart failure hospitalization at 2-years post-initiation of empagliflozin was 71.7% (95% CI = 61.6%, 79.6%) vs. 70.9% (95% CI = 64. 0%, 76.7%) for Black vs White, respectively. When adjusting for age, gender, and baseline comorbidities, there was no statistically significant difference in the risk of hospitalizations for heart failure between Black vs White patients (HR = 1. 03; 95% CI = 0.85, 1.25, p = 0.79). | In patients with type 2 diabetes with a documented previous hospitalization for heart failure prior to a prescription for empagliflozin, we found no significant difference in the cumulative probability of heart failure hospitalization in Black vs White patients. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m." @default.
• W4307805944 created "2022-11-06" @default.
• W4307805944 creator A5005950432 @default.
• W4307805944 creator A5007169111 @default.
• W4307805944 creator A5008174167 @default.
• W4307805944 creator A5027721713 @default.
• W4307805944 creator A5041228176 @default.
• W4307805944 creator A5052936533 @default.
• W4307805944 creator A5056724113 @default.
• W4307805944 creator A5059546443 @default.
• W4307805944 creator A5062399910 @default.
• W4307805944 creator A5062407829 @default.
• W4307805944 creator A5085852841 @default.
• W4307805944 date "2022-11-01" @default.
• W4307805944 modified "2023-09-26" @default.
• W4307805944 title "LBSUN162 Cumulative Probability Of Heart Failure Hospitalization Among Non-Hispanic Black Compared To Non-Hispanic White Individuals With Type 2 Diabetes On Empagliflozin (EMPA-AA): Real-world Data" @default.
• W4307805944 doi "https://doi.org/10.1210/jendso/bvac150.582" @default.
• W4307805944 hasPublicationYear "2022" @default.
• W4307805944 type Work @default.
• W4307805944 citedByCount "0" @default.
• W4307805944 crossrefType "journal-article" @default.
• W4307805944 hasAuthorship W4307805944A5005950432 @default.
• W4307805944 hasAuthorship W4307805944A5007169111 @default.
• W4307805944 hasAuthorship W4307805944A5008174167 @default.
• W4307805944 hasAuthorship W4307805944A5027721713 @default.
• W4307805944 hasAuthorship W4307805944A5041228176 @default.
• W4307805944 hasAuthorship W4307805944A5052936533 @default.
• W4307805944 hasAuthorship W4307805944A5056724113 @default.
• W4307805944 hasAuthorship W4307805944A5059546443 @default.
• W4307805944 hasAuthorship W4307805944A5062399910 @default.
• W4307805944 hasAuthorship W4307805944A5062407829 @default.
• W4307805944 hasAuthorship W4307805944A5085852841 @default.
• W4307805944 hasBestOaLocation W43078059441 @default.
• W4307805944 hasConcept C120665830 @default.
• W4307805944 hasConcept C121332964 @default.
• W4307805944 hasConcept C126322002 @default.
• W4307805944 hasConcept C134018914 @default.
• W4307805944 hasConcept C207103383 @default.
• W4307805944 hasConcept C2426938 @default.
• W4307805944 hasConcept C2775887513 @default.
• W4307805944 hasConcept C2777180221 @default.
• W4307805944 hasConcept C2778198053 @default.
• W4307805944 hasConcept C44249647 @default.
• W4307805944 hasConcept C50382708 @default.
• W4307805944 hasConcept C555293320 @default.
• W4307805944 hasConcept C61511704 @default.
• W4307805944 hasConcept C71924100 @default.
• W4307805944 hasConcept C72563966 @default.
• W4307805944 hasConcept C88879693 @default.
• W4307805944 hasConcept C98274493 @default.
• W4307805944 hasConceptScore W4307805944C120665830 @default.
• W4307805944 hasConceptScore W4307805944C121332964 @default.
• W4307805944 hasConceptScore W4307805944C126322002 @default.
• W4307805944 hasConceptScore W4307805944C134018914 @default.
• W4307805944 hasConceptScore W4307805944C207103383 @default.
• W4307805944 hasConceptScore W4307805944C2426938 @default.
• W4307805944 hasConceptScore W4307805944C2775887513 @default.
• W4307805944 hasConceptScore W4307805944C2777180221 @default.
• W4307805944 hasConceptScore W4307805944C2778198053 @default.
• W4307805944 hasConceptScore W4307805944C44249647 @default.
• W4307805944 hasConceptScore W4307805944C50382708 @default.
• W4307805944 hasConceptScore W4307805944C555293320 @default.
• W4307805944 hasConceptScore W4307805944C61511704 @default.
• W4307805944 hasConceptScore W4307805944C71924100 @default.
• W4307805944 hasConceptScore W4307805944C72563966 @default.
• W4307805944 hasConceptScore W4307805944C88879693 @default.
• W4307805944 hasConceptScore W4307805944C98274493 @default.
• W4307805944 hasIssue "Supplement_1" @default.
• W4307805944 hasLocation W43078059441 @default.
• W4307805944 hasLocation W43078059442 @default.
• W4307805944 hasOpenAccess W4307805944 @default.
• W4307805944 hasPrimaryLocation W43078059441 @default.
• W4307805944 hasRelatedWork W2042684539 @default.
• W4307805944 hasRelatedWork W2119154902 @default.
• W4307805944 hasRelatedWork W2133235702 @default.
• W4307805944 hasRelatedWork W2203903734 @default.
• W4307805944 hasRelatedWork W2618377980 @default.
• W4307805944 hasRelatedWork W2620245977 @default.
• W4307805944 hasRelatedWork W2802073086 @default.
• W4307805944 hasRelatedWork W2917746345 @default.
• W4307805944 hasRelatedWork W2982230203 @default.
• W4307805944 hasRelatedWork W3198485697 @default.
• W4307805944 hasVolume "6" @default.
• W4307805944 isParatext "false" @default.
• W4307805944 isRetracted "false" @default.
• W4307805944 workType "article" @default.